|
|
|
| 11/28/2025 16:00 |
Notice Concerning Payment Completion for the Disposal of Treasury Stock under the Employee Shareholding Association-Restricted Stock Incentive Plan |
| 10/30/2025 14:00 |
Notice Concerning Results of Joint Research with D. Western Therapeutics Institute, Inc. |
| 10/30/2025 14:00 |
Notice Concerning the Commencement of Joint Research with Kyoto University |
| 10/30/2025 14:00 |
Notice Revision of Consolidated Financial Forecast and Dividend Forecast for the Fiscal Year Ending March 31, 2026 |
| 10/30/2025 14:00 |
Consolidated Financial Results for the Six Months Ended September 30, 2025 |
| 09/02/2025 17:20 |
Determination of Disposal Price and Selling Price, etc. |
| 08/25/2025 16:00 |
Notice Concerning Disposal of Treasury Stock under the Employee Shareholding Association-Restricted Stock Incentive Plan |
| 08/25/2025 16:00 |
Notice Disposal of Treasury Stock and Secondary Offering of Shares |
| 08/25/2025 16:00 |
Consolidated Financial Results for the Three Months Ended June 30, 2025(Completion of the interim review by certified public accountants,etc) |
| 07/29/2025 15:00 |
Consolidated Financial Results for the Three Months Ended June 30, 2025 (Under Japanese GAAP) |
| 07/29/2025 15:00 |
Notice Revision of Consolidated Financial Forecast for the Six Months Ending September 30, 2025 and the Fiscal Year Ending March 31, 2026 |
| 07/15/2025 15:00 |
Notice Concerning Completion of Payment for Dispositon of Treasury Stock under the Restricted Stock Compensation Plan |
| 06/25/2025 15:00 |
Notice Concerning the Disposition of Treasury Stock under the Restricted Stock Compensation Plan |
| 06/16/2025 10:00 |
Notice Regarding Amendment to the Articles of Incorporation |
| 06/03/2025 08:00 |
Notice of Convocation Ordinary General Meeting 2025 |
| 05/14/2025 14:00 |
Consolidated Financial Results for the Fiscal Year Ended March 31, 2025 (Under Japanese GAAP) |
| 05/14/2025 14:00 |
Notice Concerning Recording of Extraordinary Losses (Impairment Losses) |
| 01/29/2025 15:00 |
Consolidated Financial Results for the Nine Months Ended December 31, 2024 (Under Japanese GAAP) |
|